Difference in Neutropenia due to Administration Schedule of TAS-102

TAS-102 significantly improves overall survival in patients with metastatic colorectal cancer. The most common adverse event of TAS-102 is bone marrow suppression, which leads to neutropenia. The incidence of neutropenia is high, and there is no known effective prevention method. Furthermore, the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Yoichiro, Aisu, Naoya, Mogi, Ai, Komono, Akira, Sakamoto, Ryohei, Kojima, Daibo, Mera, Toshiyuki, Hasegawa, Suguru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465677/
https://www.ncbi.nlm.nih.gov/pubmed/28611635
http://dx.doi.org/10.1159/000460242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465677/
https://www.ncbi.nlm.nih.gov/pubmed/28611635
http://dx.doi.org/10.1159/000460242

Ejemplares similares